BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations

作者: Donna Shattuck-Eidens

DOI: 10.1001/JAMA.1997.03550150046034

关键词: MedicineOvarian cancerRisk factorOncologyInternal medicinePredictive testingCancerBreast cancerGenetic testingFamily historyGenetic predispositionPathology

摘要: Octext. —A mutation in theBRCA1gene may confer substantial risk for breast and/or ovarian cancer. However, knowledge regarding all possible mutations and the relationship between factors is incomplete. Objectives. —To identifyBRCA1mutations to determine that best predict presence of a deleteriousBRCA1mutation patients with Design. complete sequence analysis theBRCA1coding flanking intronic regions was performed 798 women collaborative effort involving institutions from United States, Italy, Germany, Finland, Switzerland. Participanta. —Institutions selected persons representing families (1 person each family) thought be at elevated priori ofBRCA1mutation due potential factors, such as multiple cases cancer, early age cancer diagnosis, No participant family which genetic markers showed linkage theBRCA1locus. Major Outcome Measures. —Sequence variants detected this sample are presented along analyses designed predictive characteristics those testing positive forBRCA1mutations. Results. —In 102 (12.8%), clearly deleterious were detected. Fifty new alterations found including 24 mutations, unknown significance, 2 rare polymorphisms. In subset 71 Ashkenazi Jewish women, only distinct found: 185delAG 17 5382insC 7 cases. A bias prior reports exon 11 revealed. Characteristics patient's specific diagnosis (unilateral or bilateral without cancer), ethnicity, history positively associated probability her carrying deleteriousBRCA1mutation. Conclusions. —Using logistic regression analysis, we provide method evaluating woman's wide range cases, can an important tool clinicians they incorporate susceptibility into their medical practice.

参考文章(26)
JA Chambers, H Nicolai, E Solomon, CF Xu, MA Brown, B Griffiths, D Black, The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21 Oncogene. ,vol. 12, pp. 2507- 2513 ,(1996)
Steven A. Narod, Gilbert M. Lenoir, Jean Feunteun, Patricia Tonin, Bakary Sylla, Henry T. Lynch, Delphine Torchard, Marco Montagna, Olga Serova, A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. American Journal of Human Genetics. ,vol. 58, pp. 42- 51 ,(1996)
J. Wagner-Costalas, D. C. Schultz, M. Daly, D. B. Berman, H. T. Lynch, A. K. Godwin, Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: A genetic study of 15 185delAG-mutation kindreds American Journal of Human Genetics. ,vol. 58, pp. 1166- 1176 ,(1996)
Gilbert M. Lenoir, Gilbert M. Lenoir, Jean Feunteun, Sylvie Mazoyer, Sylvie Mazoyer, Olga M. Serova-Sinilnikova, Olga M. Serova-Sinilnikova, Henry T. Lynch, Nadine Puget, Nadine Puget, Delphine Torchard, A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Research. ,vol. 57, pp. 828- 831 ,(1997)
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
Sarah J Plummer, Hoda Anton-Culver, Linda Webster Jr, Barbara Noble, Shu Liao, Alexander Kennedy, Jerome Belinson, Graham Casey, None, Detection of BRCA1 mutations by the protein truncation test Human Molecular Genetics. ,vol. 4, pp. 1989- 1991 ,(1995) , 10.1093/HMG/4.10.1989
Elizabeth B. Claus, Joellen M. Schildkraut, W. Douglas Thompson, Neil J. Risch, The genetic attributable risk of breast and ovarian cancer Cancer. ,vol. 77, pp. 2318- 2324 ,(1996) , 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z
Benjamin B. Roa, Alfred A. Boyd, Kelly Volcik, C. Sue Richards, Ashkenazi Jewish Population Frequencies for Common Mutations in BRCA1 and BRCA2 Nature Genetics. ,vol. 14, pp. 185- 187 ,(1996) , 10.1038/NG1096-185
Steinunn Thorlacius, Gudridur Olafsdottir, Laufey Tryggvadottir, Susan Neuhausen, Jon G Jonasson, Sean V Tavtigian, Hrafn Tulinius, Helga M Ögmundsdottir, Jorunn E Eyfjörd, None, A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genetics. ,vol. 13, pp. 117- 119 ,(1996) , 10.1038/NG0596-117